about
High expression of miR-214 is associated with a worse disease-specific survival of the triple-negative breast cancer patients.The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian populationEvaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.Prognostic role of BRCA1 mutation in patients with triple-negative breast cancer.Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery.Epidemiological analysis of hereditary endometrial cancer in a large study population.Lynch syndrome mutations shared by the Baltic States and Poland.Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study.[Severe acute pancreatitis: role for laparoscopic surgery]A comparison of quality of life and postoperative results from combined PPH and conventional haemorrhoidectomy in different cases of haemorrhoidal disease.Morphological and immunohistochemical profile of pancreatic neuroendocrine neoplasms.Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review.High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population.An Effect of Culture Media on Epithelial Differentiation Markers in Breast Cancer Cell Lines MCF7, MDA-MB-436 and SkBr3Fibrinolytic System Changes in Liver Surgery: A Pilot Observational StudyOmadacycline for Acute Bacterial Skin and Skin-Structure InfectionsDiagnostic utility of immunohistochemical panel in various thyroid pathologiesProstate cancer trends in Latvia during 1990-2012: incidence, prevalence, mortality, and survival ratesIGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal InfectionsAllelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian populationBody mass index and nipple preservation are major contributors to satisfaction and aesthetic outcome rates after implant-based immediate breast reconstruction
P50
Q35105646-540CEF3D-1C25-43B4-BE1F-49145E07FD44Q37262027-508CF295-8D50-4776-89EE-556A589A2BE5Q37378253-BD2E1891-A09D-4A98-A04F-D7423E42B5CCQ37388751-86035582-6FFC-44E2-90E8-1B2CCBC2080AQ39486283-905ECA85-50C4-4773-8CED-787AA9A60C39Q44291088-E7EDF7D6-C8A8-4103-ABB7-BC07709CF763Q45956204-77A79C77-AA9C-4929-B36A-8A1D2B784022Q50065370-48AC276B-AD6A-43EB-A912-A677D0B91ECBQ50166640-8F5D7C93-A9E1-4A67-AFC8-F760A1FDB688Q51003505-B9AF5715-4E4B-42D5-B351-8B354B093948Q53590832-B0AB93DF-C1AF-43D5-8EAD-E233DDDE7C9CQ55206362-D9A14B06-179C-47FF-8BF3-E0AD7F09EAA1Q55226968-CF88BDDE-7AFE-4419-AB47-2DB27C5D07ABQ57825986-E8645209-D45F-4818-BD25-3362DA6E7C11Q58750602-FC1312F7-F2A2-4A2F-8F77-B61E77344A50Q61979433-A203A7D2-0553-4EF3-BEB3-CF8ED98ADD16Q84577495-D3818764-CCE9-4C0D-8FBC-921413215AF4Q86408188-3D735F92-3A49-4628-9259-67F31325C731Q90609929-1090E4E7-8C23-4E80-A1C9-4AC9A4F4DD71Q91939600-A48C223A-ACF7-491E-BFE0-C2A1EF2F8A29Q91970109-A0068BB9-4AC9-46CE-B188-D328662739F6
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Janis Gardovskis
@en
Janis Gardovskis
@nl
type
label
Janis Gardovskis
@en
Janis Gardovskis
@nl
prefLabel
Janis Gardovskis
@en
Janis Gardovskis
@nl
P106
P31
P496
0000-0001-9656-6209